Support Care Cancer
AlgorithmsAntineoplastic Combined Chemotherapy ProtocolsCytopenia
Dr. Alexander D. Fuld, MD
NPI1083639595PAC ID0143260430
- Medicare services, 2024
- 541
- Medicare patients, 2024
- 184
- Part D claims, 2024
- 427
- Publications
- 6
- Clinical trials
- 9
- Practice address
- 1 Medical Center Drive, Lebanon, NH 03756
- Practice phone
- Call (603) 650-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Fuld's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Alexander D. Fuld is a medical oncologist in Lebanon, New Hampshire
Dr. Fuld practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.
Dr. Fuld's NPI, 1083639595, was assigned on July 13, 2006. Dr. Fuld graduated from Jefferson Medical College of Thomas Jefferson University in 2002. Dr. Fuld holds New Hampshire license 15342.
NPI and contact details
- NPI
- 1083639595NPI Registry (opens in a new tab)
- Medicare PAC ID
- 0143260430
- NPI enumeration date
- July 13, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (603) 650-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Alexander D. Fuld practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire
Dr. Fuld's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.
- Dartmouth Hitchcock Medical Center1 Medical Center Drive, Lebanon, NH 03756 · Grafton CountyPhone(603) 650-5000
Source: Dmand AI Affiliation Data
Dr. Alexander D. Fuld is affiliated with 7 sites of care and 2 medical groups
Dr. Fuld's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Fuld is also affiliated with Northeastern Vermont Regional Hospital. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Fuld to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Fuld's employer is on file too: a hospital.
Northeastern Vermont Regional HospitalDartmouth Hitchcock Medical Center3 hospitalsNames with a free account2 group practices and clinicsNames with a free account1 medical groupName with a free accountEmployer: hospitalName with a free account
See all 9 affiliations for Dr. FuldSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Alexander D. Fuld's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fuld practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dartmouth Hitchcock Medical Center | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Fuld practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Dartmouth-Hitchcock Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Alexander D. Fuld is one of 24 medical oncologists in New Hampshire
Medical oncology is Dr. Fuld's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Fuld is licensed in New Hampshire.
Specialties and state licenses
- Medical oncology, New HampshirePrimary
Medical oncologists near Dr. Fuld
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
24medical oncologists in New Hampshire11medical oncologists in Lebanon11medical oncologists at Dartmouth Hitchcock Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Alexander D. Fuld billed Medicare for 541 services in 2024
CMS data shows 541 Medicare services from Dr. Fuld across 4 procedure codes in 2024, for 184 Medicare patients. Medicare paid $46,616 for them.
Medicare services, 2024541
Medicare patients184
Paid by Medicare$46,616
Procedure codes4
Dr. Fuld's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 4872024: 4841%
- Other services
- 2023: 02024: 57
Where Dr. Fuld's Medicare services took place, 2024
- In an office19636%
- In a facility34564%
Dr. Fuld compared with the New Hampshire median for medical oncologists, 2024
- Dr. Fuld
- New Hampshire median
- Medicare services
- 541vs 34855% above
- Medicare patients
- 184vs 184Close to median
- Part D claims
- 254vs 13391% above
Medians across 21 medical oncologists in New Hampshire with Dmand AI profiles that report each measure.
Dr. Fuld's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Fuld?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Fuld and other medical oncologists in New Hampshire.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Alexander D. Fuld treated 184 Medicare patients in 2024, average age 73
CMS counts 184 Medicare patients who saw Dr. Fuld in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have cancer, and 65% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Fuld's median patient age at 70, with 47% women.
Medicare patients, 2024184
Average age73
Average risk score2.49
Also on Medicaid17%
Dr. Fuld's Medicare patients by age, 2024
Dr. Fuld's Medicare patients by sex, 2024
- Women10054%
- Men8446%
Chronic conditions among Dr. Fuld's Medicare patients, 2024
- Cancer75%
- High blood pressure65%
- High cholesterol52%
- COPD40%
- Ischemic heart disease30%
- Arthritis29%
- Anxiety28%
- Mood disorders28%
Share of Medicare patients with each condition. A patient can have several.
Dr. Fuld's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women47%
- Men53%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Alexander D. Fuld wrote 427 Medicare Part D claims in 2024
In 2024, Dr. Fuld wrote 427 Medicare Part D claims for 121 patients. 71% of them were for generic drugs. CMS names the drug for 254 of them, across 11 drugs with 11 or more claims each, at $1,141,359 in total drug cost. In 2023, CMS named 222 claims across 8 drugs.
Part D claims, 2024427
Drugs named by CMS11
Total drug cost$1.1M
Part D patients121
Dr. Fuld's Part D claims by kind of drug, 2024
- Generic304 claims71%
- Brand-name123 claims29%
Dr. Fuld's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Fuld's Part D claims, 2024
- Opioids6%26 of 427 claims
- Antibiotics4%19 of 427 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 2222024: 25414%
Drugs named by CMS: 11 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Alexander D. Fuld offers telehealth to Medicare patients
Dr. Fuld accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fuld as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find medical oncologists like Dr. Fuld by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Alexander D. Fuld has 6 publications on record
Dmand AI links 6 papers to Dr. Fuld, published from 2011 to 2025. The most frequent topics are Lung Neoplasms. Dr. Fuld's most frequent co-authors are Nancy J. Burnside, MD, Mary Dickinson Chamberlin, MD and Konstantin Hristov Dragnev, MD.
Papers6
Years published2011 to 2025
Dr. Fuld's papers by year, 2011 to 2025
Topics Dr. Fuld writes about most
- Lung Neoplasms
Dr. Fuld's most frequent co-authors
- Nancy J. Burnside, MD1 shared paper
- Mary Dickinson Chamberlin, MD1 shared paper
- Konstantin Hristov Dragnev, MD1 shared paper
Recent publications by Dr. Fuld
Semin Respir Crit Care Med
ImmunotherapyLung NeoplasmsPleural Effusion, Malignant
Administration, OralAntineoplastic AgentsApoptosis
GTP-Binding Protein alpha SubunitsGTP-Binding Protein alpha Subunits, Gq-G11Magnetic Resonance Imaging
See who Dr. Fuld researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Fuld works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Alexander D. Fuld has worked on 9 clinical trials
Dmand AI links Dr. Fuld to 9 clinical trials, 4 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Adenocarcinoma of Lung. SWOG Cancer Research Network sponsors the most, 5.
Clinical trials with Dr. Fuld by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 2Phase 2/3: 2 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Fuld's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Adenocarcinoma of Lung
- Lung Neoplasms
- Rectal Diseases
Investigators on the most trials with Dr. Fuld
- Hirva Mansurali Mamdani, MD4 shared trials
- Christina Seung Baik, MD3 shared trials
- Arvinder Singh Bir, MD3 shared trials
Recent clinical trials with Dr. Fuld
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicDurvalumabCarboplatinCisplatin
A Phase IB and Randomized Open-Label Phase II Study of Berzosertib (M6620, VX-970) in Combination With Carboplatin/Gemcitabine/Pembrolizumab in Patients With Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer of Squamous Cell Histology (opens in a new tab)
Active, not recruitingPhase 1/2
Lung NeoplasmsThoracic NeoplasmsBerzosertibCarboplatinPembrolizumab
Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs (opens in a new tab)
Active, not recruitingPhase 2
Small Cell Lung CarcinomaCarcinoma, BronchogenicBerzosertibTopotecan Hydrochloride
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicPembrolizumabRamucirumabDocetaxel
Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungRucaparib
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Alexander D. Fuld received $11 in industry payments in 2018
CMS Open Payments shows 1 general payment to Dr. Fuld from 1 drug or device company in 2018. Education make up the largest share, 100% of the total. Celgene Corporation paid the most, $11.
Companies that paid Dr. Fuld the most, 2018 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Alexander D. Fuld graduated from Jefferson Medical College of Thomas Jefferson University
Dr. Fuld graduated from Jefferson Medical College of Thomas Jefferson University in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Alexander D. Fuld's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Alexander D. Fuld
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Alexander D. Fuld's NPI number?
Dr. Alexander D. Fuld's NPI number is 1083639595. It was assigned on July 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Alexander D. Fuld?
Dr. Alexander D. Fuld is a medical oncologist in Lebanon, New Hampshire. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Alexander D. Fuld practice?
Dr. Fuld practices at 1 Medical Center Drive, Lebanon, NH 03756. Dr. Fuld's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dmand AI also links Dr. Fuld to 3 hospitals, 2 group practices and clinics and 1 medical group.
What is Dr. Alexander D. Fuld's office phone number?
The practice phone on file for Dr. Fuld is (603) 650-5000.
What is Dr. Alexander D. Fuld's medical license number?
Dr. Fuld holds New Hampshire license 15342.
Which hospitals is Dr. Alexander D. Fuld affiliated with?
Dr. Fuld practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Fuld is also affiliated with Northeastern Vermont Regional Hospital. Dmand AI links Dr. Fuld to 3 more hospitals.
What medical group is Dr. Alexander D. Fuld part of?
Dr. Fuld is linked to Dartmouth Hitchcock Medical Center. Dmand AI links Dr. Fuld to 1 more medical group.
Does Dr. Alexander D. Fuld accept Medicare?
Yes. CMS data shows Dr. Fuld billed Medicare for 541 services in 2024, and Dr. Fuld accepts Medicare assignment.
Does Dr. Alexander D. Fuld offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Fuld as offering telehealth services.
How many Medicare patients does Dr. Alexander D. Fuld see?
CMS counts 184 Medicare patients who saw Dr. Fuld in 2024, with an average age of 73.
Show 7 more questionsShow fewer questions
What services does Dr. Alexander D. Fuld bill to Medicare?
In 2024, Dr. Fuld's most billed Medicare services were office visit, established patient (99215), office visit, established patient (99214) and medicare service (G2211).
Where did Dr. Alexander D. Fuld go to medical school?
Dr. Fuld graduated from Jefferson Medical College of Thomas Jefferson University in 2002.
What drugs does Dr. Alexander D. Fuld prescribe most?
In 2024 Medicare Part D data, Dr. Fuld's most prescribed drugs by claims were Prochlorperazine Maleate, Prednisone and Tagrisso.
Has Dr. Alexander D. Fuld received payments from drug or device companies?
CMS Open Payments shows $11 in general payments to Dr. Fuld from 1 company from 2018 to 2018. The largest total came from Celgene Corporation.
How long has Dr. Alexander D. Fuld been practicing?
Dr. Fuld graduated from medical school in 2002, 24 years ago.
Does Dr. Alexander D. Fuld do research?
Dmand AI links 6 publications to Dr. Fuld, published from 2011 to 2025. Dr. Fuld has worked on 9 clinical trials.
Who does Dr. Alexander D. Fuld publish with?
Dr. Fuld's most frequent co-authors are Nancy J. Burnside, MD (1 shared paper), Mary Dickinson Chamberlin, MD (1 shared paper) and Konstantin Hristov Dragnev, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in New Hampshire by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card